Cochlear Implant With Dexamethasone Eluting Electrode Array

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

July 7, 2023

Study Completion Date

February 23, 2024

Conditions
Sensorineural Hearing LossBilateral Hearing Loss
Interventions
DEVICE

CI632D

CI632 cochlear implant with Slim Modiolar electrode including dexamethasone in the electrode within wells (CI632D)

DEVICE

CI632

CI632 cochlear implant with Slim Modiolar electrode with market approval and does not include dexamethasone

Trial Locations (8)

1010

Gilles Hospital, Auckland

2145

Westmead Hospital, Sydney

3002

Royal Victorian Eye and Ear Hospital, East Melbourne

6150

Fiona Stanley Hospital, Murdoch

10010

New York Eye & Ear infirmary of Mt. Sinai, New York

10017

NYU Langone Medical Center, New York

52242

University of Iowa, Iowa City

80113

Rocky Mountain Ear Centre, Englewood

Sponsors

Lead Sponsor

Collaborators (2)

All Listed Sponsors
collaborator

NAMSA

OTHER

collaborator

Avania

INDUSTRY

collaborator

Vanderbilt University

OTHER

lead

Cochlear

INDUSTRY